Current
$71.20M
5-Year Average
$85.81M
All-Time High
$1.47B
All-Time Low
$2.57M
Market cap daily chart for Spruce Biosciences (SPRB)
Jun 14, 2021 – Jun 12, 2026 · 1,256 trading days
Market Cap growth chart for Spruce Biosciences (SPRB) from 2020 to 2026
Latest: +6.6%
Market Cap history table for Spruce Biosciences (SPRB) from 2020 to 2026
| 2026 | $71.20M | +6.6% | +$4.42M | ||
| 2025 | $66.78M | +295.2% | +$49.88M | ||
| 2024 | $16.90M | -84.6% | −$93.12M | ||
| 2023 | $110.01M | +118.6% | +$59.68M | ||
| 2022 | $50.33M | -75.2% | −$152.84M | ||
| 2021 | $203.17M | -81.6% | −$899.47M | ||
| 2020 | $1.10B | — | — |
- 2026$71.20M+6.6%
- 2025$66.78M+295.2%
- 2024$16.90M-84.6%
- 2023$110.01M+118.6%
- 2022$50.33M-75.2%
- 2021$203.17M-81.6%
- 2020$1.10B—
Market Cap values are taken from Spruce Biosciences's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Spruce Biosciences (SPRB)
According to Spruce Biosciences's latest reported financial statements, the company's latest reported market cap is $89.67M. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2026 reading of Spruce Biosciences (SPRB) market cap is $71.20M – grew 6.6% year-over-year.
Over 2021–2026 (5 years), Spruce Biosciences market cap expanded at a -18.9% compound annual rate, sustaining 2 straight years of year-over-year growth.
Spruce Biosciences market cap plunged from $1.10B in 2020 to $71.20M in 2026, a 93.5% drawdown.
The record annual market cap stands at $1.10B, reached in 2020; the historical low of $16.90M was recorded in 2024.
Spruce Biosciences Market Cap by Year
Spruce Biosciences Market Cap 2026: $71.20M
Spruce Biosciences market cap in 2026 was $71.20M, grew 6.6% from 2025.
Spruce Biosciences Market Cap 2025: $66.78M
2025's market cap for Spruce Biosciences came in at $66.78M, surged 295.2% from 2024.
Spruce Biosciences Market Cap 2024: $16.90M
Spruce Biosciences posted market cap of $16.90M in 2024, plunged 84.6% below 2023. This figure represents the lowest annual value in the available history.
Spruce Biosciences Market Cap 2023: $110.01M
In 2023, Spruce Biosciences reported market cap of $110.01M, surged 118.6% from 2022.
Spruce Biosciences Market Cap 2022: $50.33M
Spruce Biosciences market cap in 2022 was $50.33M.
See more financial history for Spruce Biosciences (SPRB).
Sector peers by Market Cap
Healthcare peers of Spruce Biosciences (SPRB), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $402.35B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $194.99B | |
| $191.70B |
- $1.07T
- $579.83B
- $402.35B
- $371.00B
- $294.03B
- $277.22B
- $194.99B
- $191.70B
Frequently asked questions
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation